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Chemical, nutritive composition and a wide range
of bioactive properties of honey mushroom
Armillaria mellea (Vahl: Fr.) Kummer
Marina Kostić, a Marija Smiljković, a Jovana Petrović, a Jasmina Glamočlija, a
Lillian Barros, b Isabel C. F. R. Ferreira, b Ana Ćirić *a and Marina Soković *a
A. mellea fruiting bodies collected from nature were chemically characterized and shown to be rich in
carbohydrates (81.25 g per 100 g dw), ash, fat and proteins (8.84 g per 100 g dw, 1.97 g per 100 g dw and
1.81 g per 100 g dw, respectively). Mannitol was the main free sugar while malic acid was the most abun-
dant organic acid. δ-Tocopherol was the dominant form of tocopherols with 42.41 μg per 100 g dw.
Polyunsaturated fatty acids were predominant, followed by saturated and monounsaturated fatty acids. A
methanolic extract prepared from these samples was tested for antioxidant, quorum sensing and anti-
microbial assays, as well as for its cytotoxicity eﬀects. The extract showed antimicrobial activity against all
tested microorganisms, including Candida albicans. Furthermore, when tested at sub-MIC concentration,
it showed reduction of virulence factors and bioﬁlm formation against Pseudomonas aeruginosa. The
extract also exhibited antioxidant activity and did not show toxicity against tumor and non-tumor cells.
Due to the observed bioactive properties and compounds of the honey mushroom and its well-balanced
nutrients, this mushroom emerges as an interesting functional food and a source of nutraceuticals with
applications in diﬀerent diseases based on antioxidant and antimicrobial eﬀects.
1. Introduction
The numerous changes of environmental factors are currently
having a huge impact on human health, which is reflected
mainly through the production of free radical species and the
damage they cause to cell structures (DNA, membranes and
proteins). Furthermore, this can lead to the development of
serious ailments such as cardiovascular diseases, stroke and
certain forms of cancer which may be fatal.1 Therefore, the
search for new products with potent biological eﬀects (includ-
ing antioxidant and antimicrobial) is in the focus of intensive
scientific studies.2 Returning to the traditional medicine of
both the East and West may be the solution to this problem,
as soon as we achieve the scientific confirmation of empirically
obtained results. Nowadays, mushrooms have become an
attractive source of drugs with few side eﬀects, which can also
be used as functional foods.3 In addition, edible mushrooms
proved to be a rich source of nutritionally appreciated and bio-
logically valuable compounds (including medicinal), some of
which showed significant antimicrobial, antioxidant, cytotoxic
and other activities.4,5 This indicates their potential beneficial
role as new active agents against the diseases of the modern era.6
Despite the progress in designing targeted biologically
active compounds, an increased number of multiple drug
resistant pathogenic microorganisms have become a serious
global problem leading to multiple fatal outcomes.7 A possible
solution to this problem may be the comprehension of the
intercellular signaling pathway which is known as quorum
sensing (QS). This phenomenon which serves for communi-
cation among bacteria includes the regulation of their gene
expression, via releasing low molecular weight compounds,
autoinducers, into the extracellular matrix where bacteria are
immersed.8 Due to its important role in various bacterial regu-
latory processes (competence, sporulation, biofilm formation,
etc.) it may serve as an important target when forming a strat-
egy for the eradication of pathogenic microorganisms, includ-
ing some of the potentially lethal opportunistic pathogens
such as Pseudomonas aeruginosa and Candida albicans.9–11
P. aeruginosa is a Gram-negative pathogenic microorganism
which can cause serious infections in immunocompromised
patients, whereas in certain patients (suﬀering from cystic
fibrosis and chronic obstructive pulmonary disorder, or those
with exposed wounds) it is a significant cause of death.11,12
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Estimates of the Health Care system in the USA are that nearly
51 000 nosocomial infections per year are caused by
P. aeruginosa. Over 13% of these infections are multidrug-
resistant, with a mortality rate of nearly 400 deaths per year.13
As for C. albicans, this yeast is considered a member of the
healthy human skin and mucosal surfaces, but under certain
circumstances, it can manifest a broad spectrum of symptoms:
from superficial to life-threatening systemic infections.14
Estimates indicate that various Candida species are the fourth
most common isolated pathogens from patients with systemic
infections.15 According to the World Health Organization data
from 2014, nearly 13.3 million people in the world are aﬀected
with oral candidiasis, and nearly 90% of them are suﬀering
from immunodeficiency diseases as well (for example
HIV/AIDS). The mortality rate of some Candida strains is
35% depending on the type and organ aﬀected with the
infection.16
Given these circumstances, where commercially available
agents are not eﬀective enough, and the number of people
with a severely compromised immune system has increased,
returning to naturally sourced substances seems like an ade-
quate solution. Studies indicate that mushrooms have a pro-
found eﬀect on the pathogenic microorganisms inhibiting
their growth.17 In addition, they act as immunostimulators,
enhancing the activity of the individual’s immune system
giving them great pharmacological and medicinal potential.18
Armillaria mellea (Vahl: Fr.) Kummer, the honey mushroom,
or zhen-mo in China,19 is an edible, medicinal mushroom
widely distributed in the coniferous forests of the Northern
Hemisphere.20 A. mellea was believed to be a highly poly-
morphic species complex, revealing approximately 40
described species with lifestyles that range from saprotrophic
to pathogenic.21 It has been traditionally used in Chinese
herbal medicine to treat headache, hypertension, epilepsy,
insomnia, neurasthenia and many other disorders.19 Also, it
has been proved to have an antihyperglycemic eﬀect.22
In the present study, we report a comprehensive chemical
analysis of A. mellea collected from Serbia, as well as some of
its biological activities (including antioxidant, antimicrobial,
antiquorum sensing and cytotoxicity). In addition, this study
provides the first data on the capacity of its methanolic extract
to interfere with quorum-sensing regulated functions (biofilm
formation, pyocyanin production, bacterial motility), which
might have great potential in the near future.
2. Materials and methods
2.1. Standards and reagents
The following reagents were purchased from Fisher Scientific
(Lisbon, Portugal): acetonitrile 99.9%, n-hexane 95% and ethyl
acetate 99.8% were of HPLC grade. The standard mixture (stan-
dard 47885-U) of fatty acid methyl ester (FAME, 37 Component
FAME Mix) was purchased from Sigma (St Louis, MO, USA), as
well as the rest of the individual fatty acid isomers, phenolic
compounds (p-hydroxybenzoic acid 99% and cinnamic acid
99%), (oxalic acid 98%, D-(+)-malic acid ≥97.0%, citric acid,
99% and fumaric acid >98%), sugars (D-mannitol ≥98% and
D-trehalose 99%) and Trolox (6-hydroxy-2,5,7,8-tetramethyl-
chroman-2-carboxylic acid 97%, used as a standard). Racemic
tocol (HPLC, 98%), 50 mg mL−1, and tocopherol standards
were purchased from Matreya (Pleasant Gap, PA, USA). 2,2-
Diphenyl-1-picrylhydrazyl (DPPH, 99.6%) was obtained from
Alfa Aesar (Ward Hill, MA, USA). Mueller–Hinton agar (MH)
and malt agar (MA) used for the cultivation of microorganisms
were obtained from the Institute of Immunology and Virology,
Torlak (Belgrade, Serbia). Dimethylsulfoxide (DMSO, 99.9%)
(Merck KGaA, Darmstadt, Germany) was used as a solvent.
Methanol and other chemicals used for analyses were of
analytical grade and purchased from common sources. Water
was treated in a Milli-Q water purification system (TGI Pure
Water Systems, USA), and sterilized for further use in the
bioassays.
2.2. Mushroom samples
The fruiting bodies of A. mellea were collected from the oak
trunks at mountain Divčibare (region of Western Serbia)
during October 2015, and authenticated by Jasmina
Glamočlija, Principal Research Fellow at the Institute for
Biological Research “Siniša Stanković”, University of Belgrade.
A voucher specimen was deposited at the Fungal Collection
Unit of the Mycological Laboratory, under the code Am-011-
2015. Fresh and cleaned fruiting bodies were randomly
divided and freezed at −20 °C, after which they were lyophi-
lized (LH Leybold, Lyovac GT2, Frenkendorf). After reaching
constant mass, they were milled into a fine powder using a
laboratory blender, mixed to obtain a homogeneous sample,
and kept at 4 °C, untill further analysis.
All determinations were carried out three times (three sep-
arate samplings) and in triplicate. Values were averaged and
reported along with the standard deviation (SD).
2.3. Chemical characterization
2.3.1. Nutritional composition. Moisture, proteins, fat,
carbohydrates and ash were determined using procedures
approved by the AOAC (2016).23 The crude protein content (N ×
4.38) was estimated by the macro-Kjeldahl method; the crude
fat was determined by extracting a known weight of the pow-
dered sample with petroleum ether, using a Soxhlet apparatus;
the ash content was determined by incineration at 600 ± 15 °C.
Total carbohydrates were calculated by diﬀerence. The energy
contribution was calculated according to the following
equation: Energy (kcal) = 4 × (g protein + g carbohydrate) +
9 × (g fat).
2.3.2. Hydrophilic compounds. Free sugars were deter-
mined using the fruiting body and analyzed by using a High
Performance Liquid Chromatography (HPLC) system, which
consisted of an integrated system with a pump (Knauer,
Smartline system 1000, Berlin, Germany), a degasser system
(KnauerSmartline manager 5000, Berlin, Germany) and an
auto-sampler (AS-2057 Jasco, Easton, MD, USA), coupled to a
refraction index detector (RIdetector KnauerSmartline 2300,
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Berlin, Germany). The extraction procedure was performed
according to Barros et al. (2008)24 whereas their identification
was made by comparing the relative retention times of sample
peaks with standards. The obtained data were analyzed using
Clarity 2.4 Software (DataApex, Prague, Czech Republic).
Quantification was based on the RI signal response of each
standard, using the internal standard (IS, raﬃnose) method
and by using calibration curves obtained from the commercial
standards of each compound. The results were expressed in
g per 100 g of dry weight.
Organic acids were determined using the fruiting body and
analyzed by ultra-fast liquid chromatography (UFLC, Shimadzu
20A series, Kyoto, Japan) coupled with a photodiode array
detector (PDA). Following the procedure described by Barros
et al. (2013),25 organic acids were quantified by comparing the
area of their peaks recorded at λ = 215 nm, with the calibration
curves obtained from the commercial standards of each com-
pound. The results were expressed in g per 100 g of dry weight.
Phenolic acids were present in the fruiting body and chro-
matographic analysis was performed as previously described
by Bessada et al. (2016).26 For double online detection, 280 nm
was used as the preferred wavelength for DAD and a mass
spectrometer (MS) was used. MS detection was performed in
negative mode, using a Linear Ion Trap LTQ XL mass spectro-
meter (ThermoFinnigan, San Jose, CA, USA) equipped with an
ESI source. The identification of the phenolic acids was per-
formed using standard compounds, when available, by com-
paring their retention times, UV-vis and mass spectra; and
also, by comparing the obtained information with available
data reported in the literature. For quantitative analysis, a cali-
bration curve for each available phenolic standard was con-
structed based on the UV signal and the results were expressed
as µg per 100 g of dry weight.
2.3.3. Lipophilic compounds. Fatty acids were determined,
after extraction using the fruiting body and transesterification
procedures described by Barros et al. (2008),24 performed with
a gas chromatograph (DANI 1000, Milan, Italy) equipped with
a split/splitless injector and a flame ionization detector
(GC-FID). The identification of the fatty acids was achieved by
comparing the relative retention times of FAME peaks from
samples with standards. The results were recorded and pro-
cessed using CSW 1.7 software (DataApex 1.7, Prague, Czech
Republic) and expressed in relative percentage of each fatty
acid.
Tocopherols were extracted using the fruiting body, follow-
ing the procedure described by Heleno et al. (2010),27 and
determined by HPLC (equipment described above, for sugar
analysis) and a fluorescence detector (FP-2020; Jasco, Easton,
MD, USA) programmed for excitation at λ = 290 nm and
emission at λ = 330 nm. The compounds were identified
by chromatographic comparison with authentic standards.
Quantification was based on the fluorescence signal response
of each standard, using the IS (tocol) method and by using
calibration curves obtained from the commercial standards of
each compound. The results were expressed in µg per 100 g of
dry weight.
2.4. Preparation of the methanolic extracts
The methanolic extracts of the honey mushroom were
obtained as follows: approximately 10 g of ground mushroom
powder was extracted with 340 mL of methanol (Carlo Erba
reagents, Italy) overnight at −20 °C, after which the suspension
was sonicated for 15 minutes, centrifuged at 3100g, and sub-
sequently filtered through Whatman No. 4 paper. The process
was followed by further extraction of the residue using an
ultrasonic bath (3 × 15 min), with three additional portions of
methanol (3 × 100 mL), and filtration of the extract through
Whatman No. 4 paper. Combined methanolic extracts were
evaporated at 40 °C on a rotary evaporator (Büchi R-210 rotary
evaporator, Flawil, Switzerland) to dryness. The methanolic
extracts were redissolved in (i) methanol (final concentration,
20 mg mL−1) for antioxidant activity evaluation, (ii) 30%
ethanol (final concentration, 30 mg mL−1) for antimicrobial
assays, or (iii) water (final concentration, 8 mg mL−1) for anti-
tumour activity evaluation.
2.5. Evaluation of the antioxidant activity
2.5.1. General. The antioxidant activity of the extracts was
evaluated by diﬀerent in vitro assays using successive dilutions
prepared from the stock solution. The sample concentrations
providing 50% of antioxidant activity or 0.5 of absorbance
(EC50) were calculated from the graphs of antioxidant activity
percentages (DPPH, β-carotene/linoleate and TBARS assays) or
absorbance at 690 nm (ferricyanide/Prussian blue assay)
against sample concentrations.28 A commercially available
agent, Trolox, was used as the standard.
2.5.2. Folin–Ciocalteu assay. The extract solution (1 mL)
was mixed with the Folin–Ciocalteu reagent (5 mL, previously
diluted with water 1 : 10, v/v) and sodium carbonate (75 g L−1,
4 mL). The tubes were mixed vigorously by vortexing for 15 s
and allowed to stand for 30 min at +40 °C for color develop-
ment, followed by the measurement of the absorbance at
765 nm (Analytikjena spectrophotometer; Jena, Germany).
Gallic acid was used to obtain the standard curve. The
reduction of the Folin–Ciocalteu reagent by the samples was
expressed in mg of gallic acid equivalents (GAE) per g of
extract.
2.5.3. Reducing power or ferricyanide/Prussian blue assay.
Briefly, the extract solutions with diﬀerent concentrations
(0.5 mL) were mixed with sodium phosphate buﬀer (200 mmol
L−1, pH 6.6, 0.5 mL) and potassium ferricyanide (1% w/v,
0.5 mL). The mixture was incubated at +50 °C for 20 min, and
trichloroacetic acid (10% w/v, 0.5 mL) was added. The mixture
(0.8 mL) was poured in a 48-well plate. The procedure was
repeated with deionised water (0.8 mL) and ferric chloride
(0.1% w/v, 0.16 mL), after which the absorbance was measured
at 690 nm using an ELX800 microplate reader (Bio-Tek
Instruments, Inc.; Winooski, USA).
2.5.4. DPPH radical-scavenging activity assay. The reaction
mixture consisting of 30 μL of the extract solutions and 270 μL
of methanol containing DPPH radicals (6 × 10−5 mol L−1) was
poured in a 96 well-plate. The mixture was left to stand in the
Food & Function Paper
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dark for 30 min, and the absorption was measured at 515 nm
using a microplate reader (Bio-Tek Instruments, Inc.,
Winooski, VT, USA).29 The radical scavenging activity (RSA)
was calculated as a percentage of DPPH discolouration using
the equation: % RSA = [(ADPPH − AS)/ADPPH] × 100, where AS is
the absorbance of the solution containing the sample and
ADPPH is the absorbance of the DPPH solution.
2.5.5. Inhibition of β-carotene bleaching or β-carotene/
linoleate assay. A solution of β-carotene was prepared by dis-
solving β-carotene (2 mg) in chloroform (10 mL). Two millilitres
of this solution were pipetted into a round-bottom flask. The
chloroform was removed at 40 °C under vacuum and linoleic
acid (40 mg), Tween 80 emulsifier (400 mg), and distilled water
(100 mL) were added to the flask with vigorous shaking.
Aliquots (4.8 mL) of this emulsion were transferred into test
tubes containing 0.2 mL of a range of concentrations of the
extract. The tubes were shaken and incubated in a water bath
at 50 °C. The zero time absorbance was measured at 470 nm,
immediately after the emulsion was added to each tube.28
β-Carotene bleaching inhibition was calculated using the fol-
lowing equation: (Absorbance after 2 h of assay/initial absor-
bance) × 100.
2.5.6. Thiobarbituric acid reactive substances (TBARS)
assay. Porcine (Sus scrofa) brains were obtained from oﬃcially
slaughtered animals, dissected, and homogenized with a
Polytron homogenizer in ice cold Tris-HCl buﬀer (20 mM, pH
7.4) to produce a 1 : 2 w/v brain tissue homogenate. The homo-
genate was centrifuged at 3000g for 10 min, after which an
aliquot (100 µL) of the supernatant was incubated for 1 h at
37 °C with 200 µL samples of a range of concentrations of the
extract in the presence of FeSO4 (10 mM; 100 µL) and ascorbic
acid (0.1 mM; 100 µL). The reaction was stopped with the
addition of trichloroacetic acid (28% w/v, 500 µL), followed by
thiobarbituric acid (TBA, 2%, w/v, 380 µL). The mixture was
then heated for 20 min at 80 °C. Centrifugation at 3000g for
10 min was performed in order to remove the precipitated
protein, whereas the color intensity of the malondialdehyde
(MDA)–TBA complex in the supernatant was measured by its
absorbance at 532 nm.29 The inhibition ratio (%) was calcu-
lated using the following formula: Inhibition ratio (%) =
[(A − B)/A] × 100%, with A and B being the absorbance of the
control and the sample solution, respectively.
2.6. Evaluation of the antimicrobial activity
2.6.1. Microorganisms and culture conditions. Gram-posi-
tive bacteria, Staphylococcus aureus (ATCC 6538), Bacillus cereus
(clinical isolate), Listeria monocytogenes (NCTC 7973), and
Micrococcus flavus (ATCC 10240), as well as the following Gram-
negative bacteria: Pseudomonas aeruginosa (ATCC 27853),
Escherichia coli (ATCC 35210), Salmonella typhimurium (ATCC
13311), and Enterobacter cloacae (ATCC 35030) were used in
order to determine the potential antimicrobial activity of the
extract. For antifungal assays, eight micromycetes were used:
Aspergillus niger (ATCC 6275), Aspergillus ochraceus (ATCC
12066), Aspergillus versicolor (ATCC 11730), Aspergillus fumiga-
tus (human isolate), Trichoderma viride (IAM 5061), Penicillium
funiculosum (ATCC 36839), Penicillium ochrochloron (ATCC
9112), and Penicillium verrucosum var. cyclopium (food isolate).
In addition, four strains of Candida albicans (all of which are
clinical isolates) were tested for their susceptibility to the
mushroom extract. Strains were isolated by rubbing a sterile
cotton swab over the oral cavities of the patients at the
Otorhinolaryngology clinic at Clinical Hospital Center
Zvezdara, Belgrade, Serbia, and determined using CHROMagar
plates (Biomerieux, France). C. albicans isolates were main-
tained on Sabouraud dextrose agar (Merck, Germany) at 4 °C
and subcultured once a month. All the tested microorganisms
are deposited at the Mycological Laboratory, Department of
Plant Physiology, Institute for Biological Research “Siniša
Stankovic”, University of Belgrade. The minimum inhibitory
(MIC), minimum bactericidal (MBC) and minimum fungicidal
(MFC) concentrations were determined by a modified micro-
dilution method.30
2.6.2. Antibacterial and antifungal assays. The minimum
inhibitory and bactericidal/fungicidal concentrations (MICs,
MBCs and MFCs) were determined using 96-well microdilution
plates (Spectar Cacak, Cacak, Serbia) with a flat bottom.30,31
The bacterial suspension was adjusted with sterile saline to a
concentration of 1.0 × 105 CFU mL−1. The methanolic extract
of A. mellea was dissolved in 30% ethanol solution and added
to Tryptic soy broth (TSB) medium (Torlak, Belgrade, Serbia).
Afterward, the bacterial inoculum was added to this mixture in
order to achieve the appropriate concentrations. The lowest
concentrations without visible growth (under a binocular
microscope) were defined as the concentrations that com-
pletely inhibited bacterial growth (MICs). The MBCs were deter-
mined by serial sub-cultivation of 10 µL into microdilution
plates containing 100 µL of broth per well and further incu-
bation for 24 h. The lowest concentration with no visible
growth was defined as the MBC, indicating 99.5% killing of
the original inoculum. Streptomycin (Sigma-Aldrich S6501,
St Louis, MO, USA) and ampicillin (Sigma-Aldrich A9393,
Germany) were used as positive controls (1 mg mL−1 in sterile
physiological saline). As for the antifungal activity, the assay
was performed in the following manner: fungal spores were
washed from the surface of agar plates with sterile 0.85%
saline containing 0.1% Tween 80 (v/v). The spore suspension
was adjusted with sterile saline to a concentration of approxi-
mately 1.0 × 105 in a final volume of 100 µL per well. The
inoculum was stored at 4 °C for further use. Dilutions of the
inoculum were cultured on solid malt agar to verify the
absence of contamination and to check the validity of the
inoculum. Minimum inhibitory concentration (MIC) determi-
nation was performed by a serial dilution technique using
96-well micro titer plates. The extract of A. mellea was dissolved
in 30% ethanol and added to malt extract broth (MEB) (Torlak,
Belgrade, Serbia), after which the appropriate concentrations
of the fungal inocula were added. The lowest concentrations
without visible growth (under a binocular microscope) were
defined as MICs. The fungicidal concentrations (MFCs)
were determined by serial subcultivation of 2 µL of the
well’s content and further incubation for 72 h at 28 °C. The
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lowest concentration with no visible growth was defined as the
MFC indicating 99.5% killing of the original inoculum.
Commercially available antifungal agents, bifonazole (Srbolek,
Belgrade, Serbia) and ketoconazole (Zorkapharma, Sabac,
Serbia) were used as positive controls.
2.7. Evaluation of the antiquorum (AQ) sensing activity
2.7.1. Bacterial strains, growth media and culture con-
ditions. The opportunistic pathogen microorganism
P. aeruginosa PA01 (ATCC 27853) was routinely grown in Luria–
Bertani (LB) medium (1% w/v NaCl, 1% w/v Tryptone, 0.5%
w/v yeast extract) (Torlak, Belgrade, Serbia), with agitation (220
rpm) at the appropriate temperature (37 °C).
2.7.2. Biofilm formation. A biofilm was grown as described
previously by Drenkard, 2002.32 The inhibitory potential of 0.5,
0.25, and 0.125 of the original MIC value of the methanolic
extract on the formation of the biofilm was tested on poly-
styrene flat-bottomed microdilution 96-well plates as described
by Spoering and Lewis (2001)33 with certain modifications.
This method in particular is designed to determine whether
the naturally sourced mushroom extract has the potential to
disrupt the cell to cell communication of PAO1, thus influen-
cing its growth and biofilm structure which provides a certain
level of endurance and resistance to antifungal agents. To
summarize, 100 μL of the overnight culture of P. aeruginosa
PAO1 was added to each well of the plates in the presence of
100 μL subinhibitory concentrations (subMICs) of the extractor
100 mL medium (control). Following incubation for 24 h at
37 °C, each well was washed twice with sterile PBS (pH 7.4), air
dried (10 min), and stained (10 min) with 0.1% crystal violet
solution in order to determine and color the biofilm mass.
The excess stain was washed with distilled water, and the
plates were left to air dry (10 min). Then 200 μL of 95%
ethanol (v/v) (Carlo Erba reagents, Italy) was added to solubil-
ize the residual color of the biofilm cells (10 min). The content
of the wells was homogenized and the absorbance at λ =
625 nm was read on a Sunrise™ –Tecan ELISA reader
(Männedorf, Switzerland).
2.7.3. Twitching and flagella motility. After growing in the
presence/absence of the mushroom extract overnight, the cells
of P. aeruginosa PA01 were washed twice with sterile PBS and
resuspended in PBS at 1 × 108 CFU mL−1 (OD of 0.1 at
660 nm). The protocol was as follows: cells of P. aeruginosa
were inoculated into nutrient agar plate with a sterile tooth-
pick and incubated overnight at 37 °C, and then they were
incubated at room temperature (+22 °C) for an additional 48 h.
Edges of the colony and the motility zone were observed and
measured under a light microscope, and described via several
characteristics such as the color and the edge of the colony,
diameter and the flagella shape.34 The subMICs of the tested
extract were mixed with 10 mL of molten LB medium and
poured immediately over the surface of a solidified LBA plate
as an overlay. The plate was point inoculated with an overnight
culture of PAO1 once the overlaid agar had solidified and incu-
bated at 37 °C for 3 days. The extent of swimming was deter-
mined by measuring the area of the colony.35
2.7.4. Anti-QS against P. aeruginosa PA01 pyocyanin. The
overnight culture of P. aeruginosa PA01 was diluted to
OD600 nm to a value of 0.2. The tested extract (dissolved as 0.5
MIC) was added to P. aeruginosa and incubated at 37 °C for
24 h. The suspension was vigorously mixed with chloroform
(5 mL) (Centrochem, Belgrade, Serbia), followed by the
addition of 0.2 M HCl (1 mL) (Zorkapharma, Sabac, Serbia).
The absorbance of the extracted pink organic layer (which
actually contains pyocyanin) was measured at 520 nm using a
UV-visible spectrophotometer (UV1601, Shimadzu, Kyoto,
Japan).36
2.8. Evaluation of the cytotoxicity in tumor and non-tumor
cells
Five human tumor cell lines, MCF-7 (breast adenocarcinoma),
NCI-H460 (non-small-cell lung cancer), HCT-15 (colon carci-
noma), HeLa (cervical carcinoma) and HepG2 (hepatocellular
carcinoma), were tested. Cells were routinely maintained as
adherent cell cultures in RPMI-1640 medium containing 10%
heat-inactivated FBS (MCF-7, NCI-H460 and HCT-15) and
2 mM glutamine, or in DMEM supplemented with 10% FBS,
2 mM glutamine, 100 U mL−1 penicillin and 100 mg mL−1
streptomycin (HeLa and HepG2 cells) at 37 °C, in a humidified
air incubator containing 5% CO2. Each cell line was plated at
an appropriate density (7.5 × 103 cells per well for MCF-7,
NCI-H460 and HCT-15 and 1.0 × 104 cells per well for HeLa
and HepG2) in 96-well plates and allowed to attach for 24 h,
after which they were treated for 48 h with the extract solu-
tions. Subsequently, the adherent cells were fixed by adding
cold 10% trichloroacetic acid (TCA, 100 mL) and incubated for
60 min at 4 °C. The plates were then washed with deionized
water and dried. Sulforhodamine B solution (0.1% in 1%
acetic acid, 100 mL) was added and the plates were incubated
further for 30 min at room temperature. The residual unbound
SRB was removed by washing the plates with 1% acetic acid.
After air drying, the bound SRB in plates was solubilized by
adding 10 mM Tris (200 mL, pH 7.4) and the absorbance was
measured at 540 nm.37
Regarding non-tumor cells, a cell culture, which was desig-
nated as PLP2, was prepared from a freshly harvested porcine
liver obtained from a local slaughterhouse. Briefly, the liver
tissues were rinsed in Hank’s balanced salt solution (100
U mL−1 penicillin and 100 mg mL−1 streptomycin), and divided
into 1 × 1 mm3 explants. Some of these explants were placed in
25 cm2 tissue flasks in Dulbecco’s Modified Eagle’s Medium
(DMEM), supplemented with 10% fetal bovine serum, 2 mM
nonessential amino acids, 100 U mL−1 penicillin, and 100
mg mL−1 streptomycin and incubated at 37 °C under a humidified
atmosphere containing 5% CO2. Cultivation of the cells was
continued by direct monitoring every 2–3 days using a phase
contrast microscope. Before confluence, the cells were sub-
cultured and plated in 96-well plates at a density of 1.0 × 104 cells
per well, and cultivated in a DMEM medium with 10% FBS,
100 U mL−1 penicillin and 100 mg mL−1 streptomycin.38 The
cells were treated for 48 h with the diﬀerent diluted sample
solutions, and the same procedure described for the SRB assay
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was followed. The results were expressed in GI50 values.
Ellipticine was used as the positive control.
3. Results and discussion
3.1. Chemical composition of Armillaria mellea
The chemical profiling of the honey mushroom was conducted
on several occasions targeting diﬀerent compounds. However,
to the best of the author’s knowledge, this is the first study on
the chemical composition of A. mellea fruiting bodies originat-
ing from Serbia. The results regarding nutritional values, and
hydrophilic and lipophilic compounds are presented in
Table 1. Carbohydrates were the most abundant compounds
with 81.25 g per 100 g dw, followed by ash (8.84 g per 100
g dw), fat (1.97 g per 100 g dw) and proteins (1.81 g per 100
g dw). With an energy value of 374.52 kcal per 100 g dw, it
represents a very good low-fat food which should be used on a
regular basis. This is in concordance with previous reports on
mushroom’s nutritional composition.39
The presence of sugars, organic acids and phenolic com-
pounds was confirmed. Mannitol was the most abundant
sugar (5.92 g per 100 g dw), while trehalose was less present in
the sample (1.72 g per 100 g dw). On the other hand, D-xylose,
D-glucose and D-galactose were detected by GC/MS from
chinese A. mellea in a study carried out by Zhang et al.
(2015).19 Regarding organic acids, malic acid was found in
5.64 g per 100 g dw, while citric, fumaric and oxalic acids were
detected in much lower amounts (0.57 g per 100 g dw, 0.52
g per 100 g dw and 0.03 g per 100 g dw, respectively). These
results are important since organic acids present in natural
matrices are involved in the reduction of oxidative stress.
In addition, phenolic compounds which have been related
to antioxidant and antimicrobial activities were also observed
in the sample: p-hydroxybenzoic acid 36.71 μg per 100 g dw
and cinnamic acid 72.89 μg per 100 g dw.
Lipophilic compounds, including fatty acids and tocoph-
erols, were characterized (Table 2). Twenty-five fatty acids
were identified, both saturated and unsaturated, with the pre-
valence of linoleic (63.80%), oleic (15.47%) and palmitic
(12.63%) acids. Polyunsaturated acids, which are considered
beneficial to human health, have been found to be predomi-
nant in A. mellea with 64.12%, followed by saturated fatty acids
(18.42%) and monounsaturated fatty acids (17.47%). Previous
reports on the A. mellea fatty acid composition revealed the
presence of 17 of these fatty acids.40
Tocopherols are powerful natural antioxidants present in
natural sources usually as a mixture of four isomers (namely
α-, β-, γ-, and δ-tocopherol).29 δ-Tocopherol was the only
isoform present in the sample (42.41 μg per 100 g dw).
3.2. Antioxidant activity of Armillaria mellea methanolic
extract
The imbalance between the production and neutralization of
reactive oxidative species within the organisms is reflected
through the accumulation of damaged cell structures (i.e. cell Ta
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membrane, proteins) that lead to oxidative stress. Mushrooms
have been described as a source of natural antioxidant com-
pounds.41 In the present study, the antioxidant activity of the
mushroom methanolic extract was evaluated through its redu-
cing power, radical scavenging activity and lipid peroxidation
inhibition. In the Folin–Ciocalteu assay (which measures the
reducing power of the extract in relation to the molybdenum
ion present in the Folin–Ciocalteu reagent), higher values
mean higher reducing power, whereas for other assays, the
results are presented in EC50 values. These results indicate
that higher values correspond to lower reducing potential
(ferricyanide/Prussian blue) or antioxidant potential (DPPH
scavenging activity, β carotene/linoleate and TBARS). All the
obtained data can be observed in Table 3.
The honey mushroom methanolic extract possesses a
significant antioxidant activity. This makes it a good candidate
for ongoing research on the use of natural substances as anti-
oxidant agents in the food industry. In addition, it may very
well increase the amount of consumed mushrooms per indi-
vidual in order to reduce oxidative stress. The highest anti-
oxidant eﬀect was measured in ferricyanide/Prussian blue
(EC50 = 1.84 mg mL
−1), followed by β-carotene/linoleate (EC50 =
3.29 mg mL−1), DPPH scavenging activity (EC50 = 4.27 mg mL
−1)
and TBARS inhibition (EC50 = 6.19 mg mL
−1) assays.
Previous results on the antioxidant activity of the A. mellea
ethanolic extract obtained from its mycelia by the DPPH
method showed the lowest scavenging activity (2, 85%).42
Zavastin et al. reported the EC50 values of 452.6 ± 2.7 μg ml−1
(DPPH method) for the hydromethanolic extract obtained
from the fruiting body of A. mellea, and the EC50 values for the
ethanolic extract were not determined.22
3.3. Antimicrobial activity of Armillaria mellea methanolic
extract
The results of antimicrobial activity indicate that the honey
mushroom methanolic extract possesses very good antifungal
activity, slightly better than its antibacterial activity. The presence
of the microbicidal eﬀect on both pathogenic bacterial and
fungal species indicates the possible presence of compounds
with a broad spectrum of activity. The antibacterial activity
was in the range of 3.12–15.00 mg mL−1 for inhibitory activity
(MIC values), and 6.25–25.00 mg mL−1 for bactericidal activity
(MBC), depending on the species. The most susceptible strains
of bacteria were S. aureus and P. aeruginosa, which may be of
significance, since these bacteria usually develop resistance to
commercially available agents.43,44 The most resistant bacteria
in the survey were L. monocytogenes, S. typhimurium and E. coli
with MBC values of 12.5 and 15.00 mg mL−1. The results of the
antifungal activity were slightly better that those of the anti-
bacterial activity (Table 4). A. fumigatus, an opportunistic patho-
gen was proved to be the most resilient to the activity of the
Table 2 Lipophilic compounds in Armillaria mellea (mean ± SD)
Fatty acids
C6:0 Caproic acid 0.119 ± 0.001
C8:0 Caprylic acid 0.074 ± 0.002
C10:0 Capric acid 0.044 ± 0.001
C12:0 Lauric acid 0.62 ± 0.02
C14:0 Myristic acid 0.328 ± 0.005
C14:1 Myristoleic acid 0.024 ± 0.001
C15:0 Pentadecanoic acid 0.66 ± 0.01
C16:0 Palmitic acid 12.63 ± 0.18
C16:1 Palmitoleic acid 1.70 ± 0.03
C17:0 Heptadecanoic acid 0.154 ± 0.002
C18:0 Stearic acid 2.839 ± 0.001
C18:1n9 Oleic acid 15.47 ± 0.06
C18:2n6 Linoleic acid 63.80 ± 0.16
C18:3n3 Linolenic acid 0.09 ± 0.01
C20:0 Arachidic acid 0.105 ± 0.001
C20:1 cis-11-Eicosenoic acid 0.091 ± 0.001
C20:2 cis-11,14-Eicosadienoic acid 0.037 ± 0.001
C20:3n3 + C21:0 cis-11,14,17-Eicosatrienoic
acid + heneicosanoic acid
0.08 ± 0.02
C20:5n3 cis-5,8,11,14,17-Eicosapentaenoic acid 0.115 ± 0.004
C22:0 Behenic acid 0.22 ± 0.01
C22:1n9 Erucic acid 0.026 ± 0.005
C23:0 Tricosanoic acid 0.045 ± 0.003
C24:0 Lignoceric acid 0.59 ± 0.03
C24:1 Ceramide 0.16 ± 0.02
Total SFA (% of total FA) 18.42 ± 0.18
Total MUFA (% of total FA) 17.47 ± 0.05
Total PUFA (% of total FA) 64.12 ± 0.13
Tocopherols
α-Tocopherol Nd
β-Tocopherol Nd
γ-Tocopherol Nd
δ-Tocopherol 42.41 ± 4.10
Sum (μg per 100 g dw) 42.41 ± 4.10
SFA, saturated fatty acids; FA, fatty acids; MUFA, monounsaturated
fatty acids; PUFA, polyunsaturated fatty acids; dw, dry weight. nd – not
detected.
Table 3 Antioxidant activity of Armillaria mellea methanolic extract (mean ± SD)
Reducing power Scavenging activity Lipid peroxidation inhibition
Folin–Ciocalteu
(mg GAE per g extract)
Ferricyanide/Prussian
blue (EC50; mg mL
−1)
DPPH scavenging activity
(EC50; mg mL
−1)
β-Carotene
(EC50; mg mL
−1)
TBARS
(EC50; mg mL
−1)
22.39 ± 0.75 1.84 ± 0.01 4.27 ± 0.48 3.29 ± 0.52 6.19 ± 0.47
The antioxidant activity was expressed as EC50 values, which means that higher values correspond to lower reducing power or antioxidant poten-
tial. EC50: Extract concentration corresponding to 50% of antioxidant activity or 0.5 of absorbance in reducing power assay. Trolox EC50 values:
18 ± 1 µg mL−1 (reducing power), 41 ± 1 µg mL−1 (DPPH scavenging activity), 41.7 ± 0.3 µg mL−1 (β-carotene bleaching inhibition) and 23 ± 1 µg mL−1
(TBARS inhibition).
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honey mushroom extract. Commercially available antimicrobial
agents, streptomycin and ampicillin for antibacterial activity
and bifonazole and ketoconazole for antifungal activity, proved
to be more eﬀective against the tested microorganisms than
the methanolic extract, but taking into account the adverse
eﬀects of these agents on the overall health of individuals, the
activity of naturally sourced products is of great importance.
There are available literature data indicating the antimicrobial
activity of the ethanolic extracts of A. mellea. Kalyoncu et al.
(2010)42 in their study confirmed the antimicrobial activity of
the ethanolic extract of honey mushroom mycelia using the
disk diﬀusion method against Gram-negative bacteria (with
IZD-Inhibition Zone Diameter in the range of 8.00–10.00 mm),
but with no activity against Gram-positive bacteria. In compari-
son to this relatively weak activity of mycelia, a study con-
ducted by Alves et al. (2012)45 with the ethanolic extract of
fruiting bodies collected in Portugal showed a significant
microbicidal eﬀect. This was confirmed against E. coli,
S. aureus, Mycobacterium smegmatis and Sporothrix schenkii as
well.46
To the best of the author’s knowledge, there are no previous
reports on the anticandidal activity of A. mellea extracts. In the
present study, four strains of C. albicans were tested for their
susceptibility to the methanolic extract, and the results indi-
cate a rather uniform activity of the extract to selected patho-
gens of clinical importance (Table 4).
3.4. Antiquorum sensing and antibiofilm formation activity
of Armillaria mellea methanolic extract
In the present study we have demonstrated that AQ sensing
compounds disrupted bacterial biofilms and made the bac-
teria more susceptible to diﬀerent antibiotics. In addition,
these compounds were also able to reduce bacterial virulence
factors. The eﬀect of the A. mellea methanolic extract on the
inhibition of P. aeruginosa biofilm formation was tested with
0.1 (0.5 MIC), 0.05 (0.25 MIC) and 0.025 mg mL−1 (0.125 MIC)
of the previously determined MICs. Table 5 shows that the
tested extract inhibits the formation of biofilms more eﬀec-
tively than antibiotics, especially at 0.5 MIC.
The initiation of biofilm formation by P. aeruginosa
depends on two cell-associated structures: the flagellum
(responsible for swarming motility) and type IV pili (respon-
Table 4 Antimicrobial activity (mg mL−1) of Armillaria mellea methanolic extract (mean ± SD)
Antibacterial activity
Armillaria mellea Streptomycin Ampicillin
MIC MBC MIC MBC MIC MBC
Staphylococcus aureus 3.75 6.25 0.13 0.30 0.10 0.20
Bacillus cereus 6.25 12.5 0.03 0.07 0.17 0.20
Micrococcus flavus 6.25 14.0 0.07 0.17 0.13 0.15
Listeria monocytogenes 12.50 21.7 0.22 0.40 0.20 0.33
Pseudomonas aeruginosa 3.12 7.0 0.13 0.23 0.40 0.67
Enterobacter cloacae 7.33 12.5 0.03 0.07 0.17 0.20
Salmonella typhimurium 12.5 23.3 0.17 0.27 0.13 0.20
Escherichia coli 15.00 25.0 0.13 0.20 0.18 0.27
Antifungal activity
Armillaria mellea Bifonazole Ketoconazole
MIC MFC MIC MFC MIC MFC
Aspergillus fumigatus 15.00 25.0 0.20 0.27 0.23 0.67
Aspergillus versicolor 6.25 12.5 0.13 0.17 0.20 0.47
Aspergillus ochraceus 3.12 6.25 0.20 0.23 0.20 0.27
Aspergillus niger 7.00 9.5 0.18 0.27 0.27 0.42
Trichoderma viride 4.38 6.25 0.20 0.17 0.83 2.00
Penicillium ochrochloron 7.5 12.5 0.20 0.33 1.33 1.67
Penicillium funiculosum 6.25 15.0 0.27 0.33 0.23 0.67
Penicillium verrucosum var. cyclopium 8.75 12.5 0.13 0.23 0.27 0.40
Anticandidal activity
Armillaria mellea Amphotericin B
MIC MFC MIC MFC
C. albicans 475/15 0.75 1.25 0.63 1.26
C. albicans 503/15 0.67 1.33 0.63 1.26
C. albicans 10/15 0.75 2.0 0.63 1.26
C. albicans 527/14 0.67 1.5 0.63 1.26
Table 5 Percentage of inhibition of Pseudomonas aeruginosa bioﬁlm
formation using Armillaria melleamethanolic extract (mean ± SD)
0.5 MIC 0.25 MIC 0.125 MIC
Armillaria mellea 69.18 45.89 17.01
Streptomycin 50.70 29.02 11.37
Ampicillin 30.86 43.54 7.85
Biofilm formation values were calculated as: (mean A620 control well)
− (mean A620 treated well)/(mean A620 control well) × 100.
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sible for twitching motility).47,48 Therefore, the aim of our
study was to determine whether the A. mellea extract can influ-
ence either one or both types of motilities. The extract insuﬃ-
ciently reduced the twitching motility of P. aeruginosa (Fig. 1),
whereas the control (culture of PA01 without the extract or
antibiotics) presented a rough appearance displaying irregular
colony edges and a hazy zone surrounding the colony (Fig. 1).
The results of the anti-QS activity of the tested extract and of
antibiotics can be observed in terms of the colony diameter
and its edges (Table 6). At sub-MIC concentrations, the dia-
meter of the tested colonies was measured, indicating the
most prominent activity of the commercially available thera-
peutic agents, followed by the activity of the mushroom
extract. In comparison with the control, both streptomycin and
A. mellea extract showed slightly reduced flagella (Fig. 1), while
ampicillin did not aﬀect the reduction of flagella at all (Fig. 1).
In addition, the mushroom extract changed the color of the
colony from green to brown.
It is known that P. aeruginosa produces a number of viru-
lence factors, and one of them is pyocyanin which is con-
sidered a virulence factor responsible for antimicrobial resist-
ance.49 To quantify the QS inhibitory activity of the extract
against pyocyanin production, a flask assay was used. The
tested methanolic extract exhibited inhibitory activity toward
the pyocyanin production in the tested concentration
(0.5 MIC). The extract showed higher reduction (38.47%) of the
pigment than streptomycin (10.96%) and ampicillin (15.84%)
(Fig. 2).
The role of QS molecules in biofilm formation and their
mechanism of action are complicated and it is assumed that
besides chemical, physical, and nutritional factors there are
some more factors and molecules that can influence this
interaction.10
3.5. Cytotoxicity of Armillaria mellea methanolic extract
Up to 400 μg mL−1, the extract did not show any cytotoxicity
for the tested human tumor cell lines (MCF7, NCI-H460,
HCT-15 and HepG2). However, the methanolic extract did not
show toxicity for non-tumor liver primary cells (PLP2; GI50 >
400 mg mL−1), which is a positive aspect. Our literature survey
indicates that armillarikin and armillaridin, compounds iso-
lated from the ethanolic extract of the A. mellea mycelium, pre-
sented significant cytotoxic potential against Huh 7, HepG2
and HA22 T cell lines.50
4. Conclusion
A detailed analysis of certain groups of compounds indicates
that A. mellea is a rich source of bioactive molecules with
potent in vitro bioactivities. According to the chemical compo-
sition and biological properties of A. mellea, this honey mush-
room might be further explored to be used as a medicinal
mushroom. Nevertheless, it is important to perform more
studies on the diﬀerent mechanisms of action involved and on
the relationship with specific bioactive compounds present in
this species.
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Fig. 1 Light microscopy images of the colony edges of Pseudomonas
aeruginosa in twitching motility, grown in the presence or absence of
Armillaria mellea extract at a concentration of 0.5 MIC. The colonies
from the bacteria grown without the extract, control (A); Pseudomonas
aeruginosa colony in the presence of streptomycin (B) and in the pres-
ence of ampicillin (C); Pseudomonas aeruginosa colony in the presence
of Armillaria mellea methanolic extract (D); magniﬁcation: (A − D) × 100.
Table 6 Twitching and motility activity of Armillaria mellea methanolic
extract at MIC 0.5 mg mL−1 (mean ± SD)
Agents
Colony diameter
(mean ± SD)
Colony
color
Colony edge on
the microscope
Control P.a. 109 11.33 ± 1.15 Green Regular flagella
Streptomycin 9.67 ± 0.58 Light brown Slightly reduced
flagella
Ampicillin 10.33 ± 1.53 Light brown Regular flagella
Armillaria mellea 10 ± 2.00 Brown Slightly reduced
flagella
Fig. 2 Reduction of the pyocyanin pigment by Armillaria mellea extract.
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